With its exclusive focus on dermatology and innovation, Galderma has established its reputation as a medical solutions provider with doctors, pharmacists and other healthcare providers. Under Nestlé’s leadership, we will be able to expand this medical heritage and portfolio even further, so that we can respond to the full spectrum of people’s skin health needs.
This will leverage Galderma’s current and future formulations over more brands and channels than today, opening up many new opportunities for growth. It will further consolidate our global leadership in dermatology and we will be well-equipped to provide a portfolio of innovative products.
Galderma will continue to operate as a stand-alone company, while enjoying the benefits of being part of one of the world’s most successful corporations. We will remain committed to the strategy we have chosen and deploy it as before, in all three businesses – Prescription, Self-medication and Aesthetic & Corrective. As always, we will maintain and constantly seek to enhance our indispensable partnership with health care providers, so that we can offer people the best medical solutions, over the course of their lives.
This is an exciting move and one that strengthens Galderma immensely, opening new doors and shedding a new light on our very bright future.
Humberto C. Antunes